
|Articles|March 15, 2002
Dual approach is safe, effective during phacoemulsification
New York-A dual approach to viscoelastic use during phacoemulsification combining 2% hydroxypropyl methylcellulose (Ocucoat, Bausch & Lomb Surgical) and sodium hyaluronate (Amvisc Plus, Bausch & Lomb Surgical) affords surgeons the opportunity to benefit from the positive features of each and allows surgery to be performed very safely and efficiently, said Robert Ditkoff, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope secures new US patent for Multi-Characteristic Opsin (MCO) technology platform
2
Glaucoma innovation: Eight themes to watch in 2026
3
FDA grants Fast Track Designation to Complement Therapeutics’ CTx001 for geographic atrophy
4
Ollin Biosciences reports positive head-to-head phase 1b data for OLN324 vs faricimab
5












































